Fitzsimon_menu

Filter by

Lohocla Research Announces FDA Clearance of Investigational New Drug Application for Kindolor, a Novel Medicinal Molecule for Treating Chronic Pain
News | Nov 01, 2023

Lohocla Research Announces FDA Clearance of Investigational New Drug Application for Kindolor, a Novel Medicinal Molecule for Treating Chronic Pain

Fitzsimons’ Depth of Expertise Display on Denver 7: Aurora's Innovation Campus Houses Dozens of Biotech Companies
News | Oct 26, 2023

Fitzsimons’ Depth of Expertise Display on Denver 7: Aurora's Innovation Campus Houses Dozens of Biotech Companies

Fitzsimons’ Collaborative Environment Showcased in Bisnow: Denver's Life Sciences Market Embracing The Mixed-Use Lab Campus Trend
News | Oct 26, 2023

Fitzsimons’ Collaborative Environment Showcased in Bisnow: Denver's Life Sciences Market Embracing The Mixed-Use Lab Campus Trend

Fitzsimons Innovation Community and Aimco Host the Community’s First-Ever Media Pitch Day
Blog | Oct 12, 2023

Fitzsimons Innovation Community and Aimco Host the Community’s First-Ever Media Pitch Day

With Aimco, Fitzsimons Innovation Community hosted members of the local and media to learn firsthand about breakthrough work from 10 of the 80+ visionary biotech and life sciences companies in the Fitzsimons Innovation Community ecosystem who are defining the future of health and care.

National Biotech Sector ‘Awakening’ to Colorado’s Ascension, Challenges Remain
News | Oct 03, 2023

National Biotech Sector ‘Awakening’ to Colorado’s Ascension, Challenges Remain

RheumaGen Selected for the Colorado BioScience Innovation Showcase for Colorado Life Sciences Innovation Forum
News | Oct 03, 2023

RheumaGen Selected for the Colorado BioScience Innovation Showcase for Colorado Life Sciences Innovation Forum

Foresight Welcomes John Truesdell to their Executive Team as New Chief Business Officer
News | Oct 03, 2023

Foresight Welcomes John Truesdell to their Executive Team as New Chief Business Officer

PharmaLogic Took Delivery of their Newest PETtrace 890 Cyclotron from GE HealthCare for the Expansion of their Fitzsimons Innovation Community Facility
News | Oct 03, 2023

PharmaLogic Took Delivery of their Newest PETtrace 890 Cyclotron from GE HealthCare for the Expansion of their Fitzsimons Innovation Community Facility

Drs. Ackerman and Shandas Discuss the Esophageal String Test on APFED's Podcast
News | Oct 03, 2023

Drs. Ackerman and Shandas Discuss the Esophageal String Test on APFED's Podcast

Fitzsimons Innovation Community and Aimco Deepen Co-Commitment to Campus Vision
News | Aug 24, 2023

Fitzsimons Innovation Community and Aimco Deepen Co-Commitment to Campus Vision

The new partnership will accelerate delivery of lab space to market. Designed for quick expansion and flexibility to respond to market needs, the development will begin with the 230,000-square-foot Bioscience 4 facility. Bioscience 4 will be the perfect space for health innovators on the frontlines of the most exciting progress in healthcare.

Gates Institute Anchors a Thriving Cell and Gene Therapy Hub in Colorado
News | Jun 12, 2023

Gates Institute Anchors a Thriving Cell and Gene Therapy Hub in Colorado

Nusano and PharmaLogic Announce Collaboration to Enable Next Generation Radiotherapeutics Development
News | May 24, 2023

Nusano and PharmaLogic Announce Collaboration to Enable Next Generation Radiotherapeutics Development